Biotech pioneer focused venture capital firm exceeds funding target 31-Mar-2022 By Jane Byrne V-Bio Ventures, a venture capital firm supporting young pioneering biotech companies raises €110m (US$122m) in its second fund, V-Bio Fund 2, exceeding its target of €100m.